EA201492268A1 - Пептиды alternaria - Google Patents

Пептиды alternaria

Info

Publication number
EA201492268A1
EA201492268A1 EA201492268A EA201492268A EA201492268A1 EA 201492268 A1 EA201492268 A1 EA 201492268A1 EA 201492268 A EA201492268 A EA 201492268A EA 201492268 A EA201492268 A EA 201492268A EA 201492268 A1 EA201492268 A1 EA 201492268A1
Authority
EA
Eurasian Patent Office
Prior art keywords
amino acid
acid sequence
seq
salt
cell epitope
Prior art date
Application number
EA201492268A
Other languages
English (en)
Russian (ru)
Inventor
Родерик Питер Хэфнер
Пол Лэйдлер
Паскаль Хики
Марк Лярш
Original Assignee
Серкешиа Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46582267&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201492268(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Серкешиа Лимитед filed Critical Серкешиа Лимитед
Publication of EA201492268A1 publication Critical patent/EA201492268A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ecology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
EA201492268A 2012-06-01 2013-05-30 Пептиды alternaria EA201492268A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1209868.7A GB201209868D0 (en) 2012-06-01 2012-06-01 Alternaria peptides
PCT/GB2013/051439 WO2013179043A1 (en) 2012-06-01 2013-05-30 Alternaria peptides

Publications (1)

Publication Number Publication Date
EA201492268A1 true EA201492268A1 (ru) 2015-05-29

Family

ID=46582267

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201492268A EA201492268A1 (ru) 2012-06-01 2013-05-30 Пептиды alternaria

Country Status (17)

Country Link
US (1) US20150098969A1 (enExample)
EP (1) EP2855515A1 (enExample)
JP (1) JP2015520771A (enExample)
KR (1) KR20150028788A (enExample)
CN (1) CN104507959A (enExample)
AU (1) AU2013269326A1 (enExample)
BR (1) BR112014029856A2 (enExample)
CA (1) CA2875130A1 (enExample)
CL (1) CL2014003290A1 (enExample)
EA (1) EA201492268A1 (enExample)
GB (2) GB201209868D0 (enExample)
HK (1) HK1201752A1 (enExample)
IL (1) IL235840A0 (enExample)
IN (1) IN2014DN10558A (enExample)
MX (1) MX2014014461A (enExample)
SG (1) SG11201407975TA (enExample)
WO (1) WO2013179043A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160130311A1 (en) * 2013-06-05 2016-05-12 Maria R. Diaz-Torres T cell epitopes derived from alt a 1 or alt a 5 for the treatment of alternaria alternata allergy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400723B (de) * 1993-08-27 1996-03-25 Biomay Prod & Handel Rekombinante alternaria alternata allergene
JP2007176953A (ja) * 1996-03-10 2007-07-12 Meiji Milk Prod Co Ltd アレルギー疾患に対するペプチド免疫療法剤
JP2003116556A (ja) * 2001-10-09 2003-04-22 Nippon Zenyaku Kogyo Kk アレルギー性皮膚炎治療剤
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
ES2402956T3 (es) * 2007-08-15 2013-05-10 Circassia Limited Péptido con formación de dímeros reducida
GB0821806D0 (en) * 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
US20130259884A1 (en) * 2010-09-24 2013-10-03 Alergenetica Sl Peptides

Also Published As

Publication number Publication date
IN2014DN10558A (enExample) 2015-08-21
AU2013269326A1 (en) 2014-12-18
KR20150028788A (ko) 2015-03-16
BR112014029856A2 (pt) 2017-07-25
IL235840A0 (en) 2015-01-29
US20150098969A1 (en) 2015-04-09
SG11201407975TA (en) 2015-01-29
CA2875130A1 (en) 2013-12-05
JP2015520771A (ja) 2015-07-23
GB201209868D0 (en) 2012-07-18
GB2517871A (en) 2015-03-04
CL2014003290A1 (es) 2015-05-22
HK1201752A1 (en) 2015-09-11
EP2855515A1 (en) 2015-04-08
MX2014014461A (es) 2015-02-10
WO2013179043A1 (en) 2013-12-05
CN104507959A (zh) 2015-04-08

Similar Documents

Publication Publication Date Title
MX2018012268A (es) Receptores de celulas t.
MY171146A (en) Compositions of glp-1 peptides and preparation thereof
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
IN2014KN01715A (enExample)
IN2014KN01713A (enExample)
BR112014000466A2 (pt) polipeptídeos quiméricos e híbridos fator viii, métodos de uso dos mesmos
IN2014KN01714A (enExample)
IN2014KN01716A (enExample)
HK1207829A1 (zh) 疫苗
MX2013013913A (es) Polipeptidos.
MX2012008998A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012009000A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
UA118167C2 (uk) Пептид та його застосування
EA201591752A1 (ru) Дипептидные и трипептидные эпоксикетонные ингибиторы протеазы
EA201490790A1 (ru) Пептидные конъюгаты агониста рецептора гастрина и глюкагон подобного пептида 1
MX350445B (es) Analogos del factor b del complemento y sus usos.
MX2019006943A (es) Polipéptidos para manejo de infecciones virales.
EA201492068A1 (ru) Гидрохлоридная соль пептида и ее применение в комбинации с другими пептидами в иммунотерапии
MX370174B (es) Peptido dendrimeros que comprenden peptidos de union a fibrinogenos.
MX360187B (es) Uso de polipeptidos derivados de pedf para promover la regeneración de músculo o tendón o arteriogénesis.
MX2014015876A (es) Peptidos de penetracion celular con eif4e como objetivo.
IN2014DN09963A (enExample)
IN2015DN00585A (enExample)
EA201391387A1 (ru) Нейропротекторные пептиды
EA202091308A1 (ru) Модифицированный вакцинный штамм brucella для лечения бруцеллеза